What does number of additional operating leases mean?

This represents the count of new operating lease agreements entered into by the company that are not yet fully integrated into the primary lease portfolio. It serves as an indicator of the company's physical expansion or operational scaling requirements. Monitoring this helps investors understand the company's commitment to future fixed-cost obligations.

Esperion Therapeutics ESPR Number of additional operating leases

Number of additional operating leases at other companies

Tarsus Pharmaceuticals, Inc.TARS

2-66.7%

Schering-PloughSGP

2—

Hillman Solutions Corp.HLMN

2—

LazardLAZ

2—

AZZAZZ

145-0.7%

HWK

HawkinsHWKN

0.80.0%

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Reported directly by Esperion Therapeutics in its filing.

Tagged under the XBRL concept espr:NumberOfAdditionalOperatingLeases.

The official record: Esperion Therapeutics’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's number of additional operating leases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's number of additional operating leases?: Esperion Therapeutics (ESPR) reported number of additional operating leases of 1 in Q4 2025.
What does number of additional operating leases mean?: This represents the count of new operating lease agreements entered into by the company that are not yet fully integrated into the primary lease portfolio. It serves as an indicator of the company's physical expansion or operational scaling requirements. Monitoring this helps investors understand the company's commitment to future fixed-cost obligations.